Owl Creek Wealth Partners’s Merck MRK Stock Holding History

Owl Creek Wealth Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$350K	Buy	2,726 +206	+8%	+$24.1K	0.1%	79
2026 Q1	$303K	Buy	+2,520	New	+$291K	0.11%	71

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Owl Creek Wealth Partners's MRK Position: Q2 2026 in Review

Owl Creek Wealth Partners increased its Merck (MRK) stake by 8.2% in Q2 2026, buying an estimated $24.1K and bringing the position to 2,726 shares worth $350K. The position accounts for 0.1% of the portfolio, ranked #79.

Owl Creek Wealth Partners first reported a position in MRK in Q1 2026 and has held it in 2 quarters since. 3,688 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Owl Creek Wealth Partners held 2,726 shares of Merck worth $350K as of Q2 2026.
Owl Creek Wealth Partners bought 206 Merck shares in Q2 2026, an estimated $24.1K.
Merck made up 0.1% of Owl Creek Wealth Partners's portfolio in Q2 2026, its #79 holding.
Owl Creek Wealth Partners first reported a position in Merck in Q1 2026 and has held it in 2 quarters since.
3,688 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Owl Creek Wealth Partners's 13F filing for Q2 2026, filed 20 Jul 2026.